Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

Portfolio Update

2 May 2007 09:57

Dunedin Enterprise Inv Trust PLC02 May 2007 Dunedin Enterprise Investment Trust PLC Investment in SWIP Private Equity Fund of Funds II PLC ("SWIP II PLC"or the "Company") • Dunedin Enterprise Investment Trust PLC has subscribed €22 million(approx Ā£15 million) for 22,000,000 C Ordinary shares of €1 each in the Company • SWIP II PLC is incorporated in Ireland as a closed end investmentcompany with variable capital and authorised by the Financial Regulator pursuantto Part XIII of the Companies Act 1990 • The Company has acquired a portfolio of 40 private equity fundcommitments from Scottish Widows plc in return for shares in the Company • The Company's portfolio is managed by Scottish Widows InvestmentPartnership Limited • The portfolio comprises commitments to large pan-European buyoutfunds, mid-market European buyout funds, European and US venture and biosciencefunds, a mezzanine and a secondaries fund • The portfolio of fund commitments comprise vintage years 2000 to 2007 • SWIP II PLC will make commitments to further private equity funds overthe coming three years This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Nov 202212:10 pmRNSHolding(s) in Company
29th Nov 20225:25 pmRNSHolding(s) in Company
29th Nov 202210:42 amRNSHolding(s) in Company
28th Nov 20229:06 amRNSHolding(s) in Company
25th Nov 20222:32 pmRNSHolding(s) in Company
22nd Nov 20227:00 amRNSResult of Tender Offer
16th Nov 202212:52 pmRNS3rd Quarter Results
16th Nov 202212:49 pmRNSResult of General Meeting
4th Nov 202210:00 amRNSHolding(s) in Company
4th Nov 20228:51 amRNSHolding(s) in Company
1st Nov 20227:00 amRNSQ3 Preliminary NAV and Tender Offer Price
21st Oct 20227:00 amRNSInterim Dividend
21st Oct 20227:00 amRNSTender Offer
7th Oct 20227:00 amRNSPortfolio Update
16th Sep 20227:00 amRNSHalf-year Report
25th Aug 20229:15 amRNSPortfolio Update
1st Aug 20227:00 amRNSPreliminary unaudited net asset value at 30/6/22
11th May 20222:58 pmRNSResult of AGM
11th May 20221:26 pmRNS1st Quarter Results
3rd May 20227:00 amRNSPreliminary unaudited net asset value at 31/3/22
13th Apr 202210:47 amRNSDirector/PDMR Shareholding
21st Mar 202212:43 pmRNSPortfolio Update
18th Mar 20227:00 amRNSAnnual Financial Report
2nd Mar 202212:41 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSDividend Declaration
1st Feb 20227:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/21
16th Dec 20213:28 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSPortfolio Update
8th Dec 202110:05 amRNSListing Rule 9.6.14
1st Dec 202110:02 amRNSDirector/PDMR Shareholding
1st Dec 202110:01 amRNSDirector/PDMR Shareholding
26th Nov 202112:45 pmRNSDirector/PDMR Shareholding
26th Nov 202112:44 pmRNSDirector/PDMR Shareholding
26th Nov 202112:42 pmRNSDirector/PDMR Shareholding
24th Nov 20217:56 amRNSDirector/PDMR Shareholding
24th Nov 20217:54 amRNSDirector/PDMR Shareholding
24th Nov 20217:46 amRNSHolding(s) in Company
19th Nov 20218:18 amRNSHolding(s) in Company
19th Nov 20217:00 amRNS3rd Quarter Results
16th Nov 20217:00 amRNSResult of Tender Offer
10th Nov 202111:43 amRNSResult of General Meeting
1st Nov 20217:00 amRNSQ3 Preliminary NAV and Tender Offer Price
18th Oct 20219:20 amRNSTender Offer
13th Oct 202110:00 amRNSPortfolio Update
6th Oct 20217:00 amRNSDividend Declaration
21st Sep 202110:00 amRNSCapital Reorganisation
16th Sep 20217:00 amRNSHalf-year Report
2nd Aug 20217:00 amRNSPreliminary Unaudited Net Asset Value at 30/6/21
30th Jul 202112:25 pmRNSCapital Reorganisation
7th Jul 20211:13 pmRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.